All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
Therapeutic and/or diagnostic medical devices having one or more electrodes have been described. For example without limitation, catheters with electrodes carried by one or more expandable or deformable members have been described. Depending on the design and use, some previously described medical device with one or more electrodes may have some deficiencies or drawbacks. The disclosure herein describes examples of devices and methods of use that provide some advantages to those previously described.
The disclosure includes a tissue ablation and visualization apparatus, comprising: an inflatable balloon disposed at a distal region of an elongate shaft; an ablation element carried by the balloon; a first lens disposed inside the inflatable balloon and providing a first field of view; and a second lens disposed inside the inflatable balloon and providing a second field of view different than the first field of view, the second lens axially spaced at a fixed distance from the first lens.
The apparatus can include a first image sensor disposed inside the inflatable balloon, the first image sensor positioned to receive light passing through the first lens, and a second image sensor disposed inside the inflatable balloon, the second image sensor positioned to receive light passing through the second lens, the second image sensor axially spaced at a fixed distance from the first image sensor.
The apparatus can further include a third lens disposed inside the inflatable balloon, the third lens axially spaced at a fixed distance from the first lens. The apparatus can further include a third image sensor disposed inside the inflatable balloon, the third image sensor positioned to receive light passing through the third lens, the third image sensor axially spaced at a fixed distance from the first image sensor. The apparatus can further comprise a fourth lens disposed inside the inflatable balloon, the fourth lens axially spaced at a fixed distance from the second lens. The first and fourth lenses can be axially aligned, or are at a fixed axial distance from each other that is less than the distance between the first and second lenses. The apparatus can further comprise a fourth image sensor positioned to receive light passing through the fourth lens, the fourth image sensor axially spaced at a fixed distance from the second image sensor. The second and third lenses can be axially aligned, or are at a fixed axial distance from each other that is less than the distance between the first and second lenses.
The apparatus can further comprise a third lens disposed inside the inflatable balloon, the third lens axially spaced at a fixed distance from the first lens. The apparatus can further comprise a fourth lens disposed inside the inflatable balloon, the fourth lens axially spaced at a fixed distance from the second lens.
The apparatus can further comprise a visualization housing assembly disposed inside the balloon, the visualization housing assembly comprising the first and second lenses. The apparatus can further comprise an elongate member disposed within the balloon and extending axially through the balloon, the elongate member secured to a distal end of the balloon, the elongate member disposed within the visualization housing assembly and axially moveable relative to the visualization housing assembly.
The apparatus can further comprise a plurality of electrodes carried by the balloon, each of the plurality of electrodes having a portion disposed at an apex of the balloon. The apparatus can further comprise a plurality of second electrodes carried by the balloon, each of which has a distal end that extends further distally than distal ends of each of the plurality of electrodes.
The disclosure includes a tissue ablation device, comprising: an inflatable balloon disposed at a distal region of an elongate shaft; a flexible circuit, carried by the balloon, comprising first and second arms spaced from one another along at least a portion of their lengths, the first arm comprising a first conductive member and the second arm comprising a second conductive member, the first conductive member extending to a proximal region of the first arm, and the second conductive member extending to a proximal region of the second arm; and a first electrode in electrical communication with the first conductive member, and a second electrode in electrical communication with the second conductive member, wherein the first arm has a proximal end that extends further proximally than a proximal end of the second arm.
The first and second arms can each comprise a substrate to which the respective conductive members are secured, each of the substrates extending to proximal ends of the respective arms.
Each of the first and second conductive members can include a proximal pad that is an electrical extension of the respective trace.
The first and second electrodes can be non-integral with their respective conductive members. Each of the electrodes can be disposed over a respective arm.
The first and second electrodes can be part of the first and second arms, respectively, the first and second electrodes being part of the same layer of material as the conductive members.
The device can further comprise a plurality of first arms, the first arm being one of the plurality of first arms, and a plurality of second arms, the second arm being one of the plurality of second arms, each of the plurality of first arms having a proximal end that extends further proximally than a proximal end of each of the plurality of second arms. The plurality of first arms and the plurality of second arms can be carried by the balloon in an alternating arrangement around at least a portion of the balloon. Each of the plurality of first arms can be adjacent to two of the plurality of plurality of second arms, and each of the plurality of second arms is adjacent to two of the plurality of first arms around the balloon. The plurality of first arms can comprise at least four arms, and wherein the plurality of second arms comprises at least four arms. Each of the plurality of first and second arms can comprise at least six arms. Each of the plurality of first arms can have a proximal end that extends to the same axial position along the device as each of the other proximal ends of the plurality of first arms. Each of the plurality of second arms can have a proximal end that extends to the same axial position along the device as each of the other proximal ends of the plurality of second arms.
The first arm can comprise a third conductive member extending to a proximal region of the first arm, the first conductive member having a proximal end that extends further proximally than a proximal end of the third conductive member, the third conductive member being in electrically communication with a third electrode.
The disclosure includes a tissue ablation device, comprising: an inflatable balloon disposed at a distal region of an elongate shaft; a substrate secured to an outer surface of the balloon, the substrate comprises a plurality of protrusions extending laterally and distally from at least one side of the substrate, the plurality of protrusions enhancing the substrate's adhesion to the balloon; an adhesive disposed between first and second of the plurality of protrusions, and in contact with the balloon; and a conductive element secured to the substrate and in electrical communication with an electrode.
The plurality of protrusions can extend laterally from first and second sides of the substrate.
At least 50% of the plurality of protrusions can have the same general configuration.
At least some of the plurality of protrusions can comprise two sides that are generally parallel.
At least some of the plurality of protrusions have a width from 0.001 inch to 0.5 inches.
At least some of the plurality of protrusions have a length from 0.001 inches to 0.05 inches.
At least some of the plurality of protrusions are axially spaced from 0.001 inches to 0.5 inches apart.
The substrate can comprise at least 5 protrusions on a first side. The substrate can comprise at least 5 protrusions on a second side.
The electrode can be disposed over the substrate covering at least some of the plurality of protrusions.
The disclosure includes a tissue ablation device, comprising an inflatable balloon disposed at a distal region of an elongate shaft; and a flexible circuit, carried by the balloon, comprising a plurality of arms spaced apart from one another along at least a portion of their lengths, wherein each of the plurality of arms comprises at least one ablation electrode, and wherein a first arm is adjacent to a second arm, the first arm having a different number of ablation electrodes than the second arm.
The plurality of arms can comprise a plurality of first arms and a plurality of second arms, the plurality of first arms having a first number of ablation electrodes, and the plurality of second arms having a second number of ablation electrodes different than the first number of ablation electrodes.
The plurality of arms can be arranged around the balloon such that the plurality of first arms and the plurality of second arms are in an alternating arrangement. The plurality of first arms can each have two ablation electrodes, and the plurality of second arms each have one ablation electrode. The plurality of arms can be arranged around the balloon such that the plurality of first arms and the plurality of second arms are in an alternating arrangement. The first and second arms can each comprise a mapping electrode.
The plurality of first arms can each include an electrode that is part of a first array of electrodes axially aligned along the length of the balloon. The plurality of second arms can each include an electrode that is part of a second array of electrodes axially aligned along the length of the balloon, the second array axially spaced from the first array. The plurality of second arms can also each comprise an electrode that is part of the first array of electrodes axially aligned along the length of the balloon.
The disclosure includes a tissue ablation device, comprising: an inflatable balloon disposed at a distal region of an elongate shaft; a plurality of electrodes carried by an outer surface of the balloon, each of the plurality of electrodes sized and positioned such that any two adjacent electrodes will, when activated in bipolar mode and with a power input 25 W or less, optionally 15 W or less, cause a complete burn to occur in tissue between the two electrodes.
The disclosure includes a method of ablating tissue at certain power densities, comprising: providing expandable device comprising an inflatable balloon and a plurality of electrodes carried thereby; moving at least two of the plurality of electrodes into contact with tissue; delivering RF energy between two adjacent electrodes in bipolar mode, at a power of 25 W or less, optionally 15 W or less, to create a power density based on the surface area of the electrodes and the space between the electrodes, of 40 W/cm2 or less; and ablating tissue between the two electrodes by delivering the RF energy.
The disclosure includes a method of ablating tissue at certain power densities, comprising: providing expandable device comprising an inflatable balloon and a plurality of electrodes carried thereby; moving at least two of the plurality of electrodes into contact with tissue; and delivering RF energy between two adjacent electrodes in bipolar mode such that the energy density is 40 W/cm2 or less.
The disclosure includes a tissue ablation device, comprising: an inflatable balloon disposed at a distal region of an elongate shaft; and a plurality of distal electrodes carried by an outer surface of the balloon, and a plurality of proximal electrodes carried by an outer surface of the balloon, the proximal electrodes and distal electrodes all having substantially the same surface area, optionally within 5% of each other, wherein the proximal electrodes have a first configuration and the distal electrodes have a second configuration, the first and second configurations being different.
In
The disclosure describes methods of, and systems and devices configured for, diagnosing, preventing, and/or treating cardiac arrhythmias. The disclosure includes methods of and devices configured for ablating cardiac tissue. The disclosure is related to and incorporates by reference the devices and methods described in U.S. Pat. No. 8,295,902, issued Oct. 23, 2012, and U.S. Pub. No. 2012/0071870, published Mar. 22, 2012, the disclosures of which are incorporated by reference herein. Devices herein can incorporate suitable structural features in embodiments in the aforementioned applications even if the disclosure fails to expressly include them. Additionally, the methods of use herein can include suitable method steps in embodiments in the aforementioned applications even if the disclosure fails to expressly include them.
The cardiac ablation catheter is configured to deliver ablative energy to tissue such as cardiac tissue and to ablate the tissue. Expandable member 10 includes membrane, or balloon, 12 and a plurality of energy delivery elements 14 secured to the exterior of membrane 12. In this embodiment energy delivery elements 14 are electrodes configured and positioned to deliver ablative RF energy to tissue when expandable member 10 is inflated and to ablate the tissue, and are in electrical communication with an RF generator (not shown) configured to generate RF energy.
Visualization system 30 includes a camera assembly 32 and illumination sources 35 disposed on the guide wire shaft 54. The cameras are configured to enable real-time imaging of the procedure from within the expandable member 10 to visualize the membrane and electrodes, cardiac tissue when the membrane/electrodes and cardiac tissue interface, as well as lesion formation during the ablation procedure, as is described in more detail below.
The materials of the membranes 12 described herein can vary. Generally, the membrane material is thin, readily foldable into a low profile and refoldable after expansion. The materials can be elastic, inelastic, stretchy, non-stretchy, compliant, semi-compliant, or non-compliant. In an embodiment, membrane 12 has an expandable structure and can be constructed of materials such as those materials used in the construction of balloon catheters known in the art, including, but not limited to polyvinyl chloride (PVC), polyethylene (PE), cross-linked polyethylene, polyolefins, polyolefin copolymer (POC), polyethylene terephthalate (PET), nylon, polymer blends, polyester, polyimide, polyamides, polyurethane, silicone, polydimethylsiloxane (PDMS) and the like. Membrane 12 can be constructed of relatively inelastic polymers such as PE, POC, PET, polyimide or a nylon material. Membrane 12 can be constructed of relatively compliant, elastomeric materials including, but not limited to, a silicone, latex, urethanes, or Mylar elastomers. Membrane 12 can be embedded with other materials such as for example, metal, Kevlar or nylon fibers. Membrane 12 can be constructed of a thin, non-extensible polymer film such as polyester or other flexible thermoplastic or thermosetting polymer film. In one embodiment flexible membrane 12 can be about 0.001″ to about 0.002″ in thickness to provide sufficient burst strength and allow for foldability. In some embodiments it is preferable to have the electrode mechanical properties as close to the membrane mechanical properties as possible. One way of providing this is to use an inelastic membrane that will not stretch as it is expanded. This helps secure the branches to the membrane. Membrane 12 has a front, or distal, face that is generally flat but can have other shapes as well.
Expandable member 10 includes what is generally referred to in U.S. Pat. No. 8,295,902, issued Oct. 23, 2012, and U.S. Pub. No. 2012/0071870, published Mar. 22, 2012, as flex circuits. A flex circuit as used herein generally refers to a conductive layer, an insulation layer, and optionally a substrate layer. A flex circuit is in electrical communication with at least one electrode.
The conductor or conductive layer 15 can be a material such as, but not limited to, a metal or metal foil of copper, gold, silver, tin, nickel, steel, cupronickel (copper-nickel alloy), KOVAR (nickel-cobalt ferrous alloy) or other material. In an embodiment, more than one conductive material can be used in the conductive layer 15. In an embodiment, a conductive layer 15 of copper can be plated with a thin layer of an additional conductive material at the conductive pad beneath electrode 14. In an embodiment, the thin layer of additional conductive material can be gold. The flex circuit and its components can be manufactured using techniques as known in the art.
The materials used to create the electrodes 14 can vary. The electrodes 14 can be a thin film of an electro-conductive or optical ink. The ink can be polymer-based for better adhesion to the membrane. The electrode material can be a biocompatible, low resistance metal such as silver, silver flake, gold, and platinum which are additionally radiopaque. Inks may additionally comprise materials such as carbon and/or graphite in combination with the more conductive materials already described. The addition of carbon and/or graphite can increase the conductivity of the polymer matrix. When incorporated as fibers the carbon and/or graphite add additional structural integrity to the ink electrode. Other fiber materials may be substituted to attain the same end. When the electrode material is not particularly radiopaque, additives such as tantalum and tungsten may be blended with the electrode material to enhance radiopacity. An example of an electro-conductive ink is provided by Engineered Conductive Materials, LLC (ECM) which is a polyurethane-based silver loaded ink. Another example is Creative Materials Inc., which manufactures conductive inks, films, as well as radiopaque inks. As mentioned above, the electrodes 14 can be applied to the membrane 12 and flex circuit using an adhesive. Alternatively, the electrode material can have adhesive properties or be an adhesive-loaded with conductive particles such as silver flakes such that electrodes 14 can adhere the components of the flex circuit to the membrane 12. If an additional adhesive layer is used to adhere the electrode 14 to the membrane 12 and flex circuit, the adhesive layer can include a conductive or non-conductive material. The electrodes formed with electro-conductive or optical ink or thin metal film can be visualized under fluoroscopy to provide a general sense of the shape of the membrane and location of the electrode. To enhance visualization under fluoroscopy, radiopaque additives can be included in the electrode material or radiopaque markers laid out next to, on top or below the electrodes as will be discussed in more detail below. Additionally, the bonding layer or substrate will be optimally comprised of a minimally reflective material.
Each of the electrodes is individually addressable, or can be used with any other electrode. The electrodes can operate in monopolar mode or bipolar mode, as is indicated in the exemplary schematic shown in
To prevent or reduce the likelihood of charring of tissue that is in contact with the energy delivery elements and coagulation of blood adjacent the electrodes, each of the flex circuits at the locations of the electrodes includes an irrigation aperture therethrough, and as shown are in the center of the electrodes. The irrigation apertures also prevent the inflation/irrigation fluid inside the membrane from becoming too hot, which would interfere with the ablation. Irrigation fluid, which is also the fluid that inflates membrane 12 causing it to be reconfigured toward its expanded configuration, is pumped from a fluid source through irrigation lumen 52, into membrane 12, through the irrigation apertures (not labeled), and towards the tissue that is in contact with the electrodes to cool the target tissue. One of the drawbacks of previous attempts at cardiac ablation is that the ablation procedures cause blood to coagulate or tissue to char due to lack of a cooling feature. Additionally, since each electrode is individually addressable, and the visualization system allows the operator to identify whether an individual electrode is in contact with tissue, only electrodes in contact with tissue may be turned on. Thus energy is more efficiently coupled to just the sites where ablation is desired and little to no energy is dissipated into the blood.
One of the significant advantages of ablation catheters herein is that, when in use, the ablation procedures can be visualized with an imaging, or visualization, member with a perspective from within the inflatable membrane. In the embodiment in
Illumination sources 35 are configured and positioned to provide illumination generally radially outward towards reflector 22. Diffuse reflector 22 thus diffusely reflects light forward toward the camera's fields of view. The illumination sources thus provide lighting for the cameras to visualize the procedure, including the tissue, and the lesion formation.
In some embodiments the diffuse reflector is printed on the exterior of the balloon. The diffuse reflector can be comprised of silicone or urethane resins filled with nonconductive white pigment such as TiO, BaO, BaSo4, styrene or other polymer beads, or of metal particles. Optimal materials will be minimally reflective such as a black adhesive.
In this embodiment the diffuse reflector is secured to the membrane such that it does not completely overlap any of the electrodes, and is positioned so that the illumination sources, when activated, emit light towards the reflector. In this embodiment the diffuse reflector, or reflectors, is secured to the membrane at a location that does not extend all the way to the distal end of the membrane. In this embodiment the reflector is secured to the membrane such that it does not extend further distally than the proximal-most electrode. In alternative embodiments, however, the reflector can extend distally to the proximal-most electrode in some locations around the membrane. For example, the distal edge of the reflector can be curved rather than straight, and depending on the electrode layout on the membrane, some portions of the reflector may extend distally relative to the proximal-most electrode. If the membrane in its inflated configuration can be divided in half between the distal most location and proximal most location defining a distal portion and proximal portion, the reflector is disposed at least on the proximal portion. In the embodiment shown in
One aspect of the disclosure is an expandable member that includes a diffuse reflector but does not include any ablation element. For example, medical devices that include an inflatable member and at least one camera and at least one light source therein can benefit from a diffuse reflector even if the device is not used for ablation procedures.
While the reflector herein is described as being a diffuse reflector, there may be some uses in which a reflector that reflects light in a specular manner may be beneficial. Alternatively, a reflector can have portions that reflect light in a diffuse manner and portions that reflect light in a specular manner.
As set forth above, light is reflected from the diffuse reflector to provide illumination in the field of the view of the at least one camera. The field of view of the camera can include the view of an electrode secured to the membrane. As set forth herein, the electrodes can be highly reflective, such as if they are comprised of silver. Reflective electrodes causes light incident upon the electrodes to reflect into the camera field of view, which can cause the electrodes to appear as bright spots on the display, possibly interfering with viewing the procedure. It can thus be beneficial to include in the catheter a reflection adjuster that is adapted to reduce specular reflection of light from at least one of the plurality of ablation electrodes into the field of view of an imaging member.
In some embodiments the reflection adjuster is a light absorber. The light absorber can be positioned between the bottom of the electrodes and the membrane. In some embodiments the light absorber is a black adhesive that adheres portions of the electrode to the membrane, as well as acts as a light absorber.
In some embodiments the reflection adjuster is an anti-reflective coating. Exemplary anti-reflective coatings include, for example without limitation, a deposited thin layer of TiO2, MgF2, and “moth eye” structures comprised of nanoparticles approximately 200 nm in diameter spaced 300 nm range, random microstructure secured to or created on the interior surface of the membrane that is adapted to reduce reflection. The anti-reflective coating can be adhered to only a portion of the membrane, such as the portion where the electrodes are disposed. For example, an anti-reflective coating could be applied to only the distal portion of the inner membrane.
A reflection adjuster will reduce the amount of reflection from the bottom of the electrodes, creating a clearer image of the membrane and electrodes from within the membrane.
When the images or video provided by the at least camera are displayed on the display, it can be helpful to be able to visually identify the electrodes on the display. For example, a user interface can be used to control delivery parameters for any of the electrodes, and enabling the physician to easily determine and confirm that a given electrode on the video is a particular electrode on the user interface simplifies the procedures and ensures that the correct electrodes are being activated and used as intended.
In some embodiments the catheter includes an electrode identifier associated with at least one of the plurality of electrodes, and is some embodiments the catheter includes an electrode identifier with each of the plurality of electrodes. The electrode identifier need not be unique to each of the electrode, but in some embodiments it is unique to each electrode. The electrode identifier is visually identifiable and allows an individual to visually associate the identifier with an electrode.
In some embodiments the electrode identifier is an alphanumeric characters disposed on or near each of the electrodes. An example of this type of identifier is described and shown below. For example, an alphanumeric character can be printed on the back of an electrode, or the back of a portion of the flex circuit that is associated with an electrode. An alphanumeric character can also be printed on the membrane near the electrode so that the identifier can be easily associated with a particular electrode.
In some embodiments the electrode identifiers are colors associated with one or more of the electrodes. For example, the electrodes can be color-coded so that a user can visually identify each of the electrodes. In some embodiments a group of electrodes can have a particular color, such as all of the electrodes connected to the same flex circuit are all one color. An additional example of an electrode identifier is the shape of the electrode so that the electrode or group of electrodes can be visually identified based on their shape. For example, groups of electrodes can be circular, oval, hexagonal, rectangular, square, etc. Each electrode could have a unique shape to it as well.
An example of electrode identifiers is described below in the context of overlaying field of view images from a plurality of cameras.
Exemplary materials for the membrane and flex circuit materials can be found in U.S. Pat. No. 8,295,902, issued Oct. 23, 2012; U.S. Pub. No. 2012/0071870, published Mar. 22, 2012. Additional examples of membrane material include PET, Polyurethane, etc. Exemplary materials for the reflector include metalized paints, silicone or urethane resin filled with nonconductive white pigment such as TiO or BaO or BaSo4, preferably non-conductive. Exemplary materials for the electrodes include silver filled silicone or urethane. Exemplary materials for the conductive traces are conductive metals including copper or other such conductive materials. The insulation layers can be known dielectric materials. Exemplary materials for the substrate include Kapton.
In use, the visualization system allows for real-time visualization of the procedure with a view by one or more cameras disposed within the balloon. The visualization allows for the entire procedure to be visualized, allowing physicians to assess the degree of tissue contact, and see the electrodes, tissue, and lesion formation as it occurs. For clarity,
The description herein of overlaying camera field of views is related to the disclosure in U.S. Pub. No. 2012/0071870, in particular FIGS. 38H-38R, and the textual descriptions thereof. One aspect of this disclosure is an exemplary method of generating a panoramic image display using images from a plurality of cameras attached to an endoscopic catheter. In some embodiments a plurality of images captured from a plurality of cameras are overlayed with at least one other image to create the panoramic image around the longitudinal axis of the ablation catheter. Two or more cameras can image various sections of the expandable member (from within the expandable member) and the anatomy, and the geometric relationships between the cameras are either known a priori (by design or measurement), or can be estimated from the images themselves using common anatomical features of the balloon as landmarks.
In general, for each camera, a mapping function that maps a pixel into a virtual unwrapped display screen, e.g. a dome-shaped screen, surrounding the cameras is computed. The images are then projected back to this virtual display screen using inverse projection, i.e., using cameras as projectors. Data in overlapping regions are combined using compositing including blending or some other means.
Furthermore, the image captured by the camera can have lens barrel aberration.
The mapping function that maps the original pixel coordinates, P(u, v), to a distorted pixel coordinate system due to barrel aberration, {tilde over (P)}(ũ, {tilde over (v)}), can be determined by using the grid target:
The 3D surface of the ellipsoidal balloon can be unwrapped into a 2D plane using the parameterization shown in
A point on the balloon surface can be: (x, y, z). A planar unwrapped image can be constructed from the ellipsoidal balloon geometry by unwrapping the balloon surface as follows:
Where:
θ=g(m) (5)
and g(m) is the well-known “Complete Elliptic Integral of the Second Kind.” The unwrapped 2D surface is defined by the polar coordinates: (m, γ) or in rectilinear coordinates, ({tilde over (x)}, {tilde over (y)}), where:
In summary, the parameters in Table 1 (below) describe the camera geometry of this multi-camera system.
Using the parameters of Table 1, the ({tilde over (x)}, {tilde over (y)}) coordinates of the point on the unwrapped balloon corresponding to each pixel in an image produced by a given camera can be computed. Then the intensity of that pixel can be painted on the unwrapped balloon surface. If more than one camera projects data on to the same location on the unwrapped balloon surface, the data can be combined using any number of exemplary ways, such as blending, maximum value, adaptive blending, alpha blending, weighted averaging, etc. These techniques fall into the general category of “Compositing” as described in Foley et al., “Computer Graphics Principles and Practice”, 1990, Addison Wesley, 2nd Edition. ISBN 0-201-12110-7. In the overlapping areas of images from two or more cameras, the underlying anatomical structure may be slightly misaligned even after following the above steps to grossly align the image due to inaccuracies in the geometric model. In this case, a given tissue structure may appear twice in the overlapping area, similar to double vision. To address this problem, images can be locally warped by using feature tracking. See U.S. Pat. No. 6,659,953, issued Dec. 9, 2003 to Sumanaweera et al., titled “morphing diagnostic ultrasound images for perfusion assessment,” for a description of an exemplary local warping technique.
In
The exemplary method above acquires an image from each of a plurality of cameras, and combines the images to produce a panoramic image. As set forth above, the images from each camera can be deformed using a geometric transformation. The deforming can comprise information associated with the known geometric relationship between the cameras. The deforming procedure can comprise geometric transformations generated using compositing in the overlapping areas of the images. The procedure can comprise the use of weighted averaging. The procedure comprises alpha blending. The deforming procedure can comprise geometric transformations generated using feature tracking in the overlapping areas of the images. The characterization of the geometric relationship between the cameras can comprise the use of experimentally determined optical targets. The geometric relationship can be determined analytically by geometrically modeling the cameras, the fixture containing the cameras and the balloon. The geometric transformation can include geometric transformations that map the balloon onto a planar surface while maintaining the distance between any arbitrary set of points on the 3D surface.
In an exemplary method of use, the catheter is used to ablate cardiac tissue in the treatment of a cardiac arrhythmia. The catheter is advanced into the left atrium using known access procedures including guide wire and guide catheter techniques. Inflation/irrigation fluid is then pumped from a fluid source down inflation/irrigation lumen 52 to inflate the balloon to the configuration shown in
Once it has been determined, depending on the visualization information such as proper placement around a pulmonary vein or mapping electrical information, that the balloon has been properly positioned at the treatment site, an external console, generally shown in
The generator is configured such that electrodes can be used to map tissue, ablate tissue, and stimulate tissue, as desired. Ablation of cardiac tissue to treat aberrant signals is described generally herein and known. The generator is also configured, however, to generate and deliver electrical tissue stimulation signals to the electrodes so that the electrodes stimulate the cardiac tissue. The schematic in
Stimulation of the cardiac tissue can be done for a number of reasons. In an exemplary embodiment stimulation of tissue can be performed during a diagnostics procedure to make sure the electrodes are working. For example, RF energy can be delivered to a first electrode and sensed with another electrode, thereby transferring energy between pairs of electrodes to make sure the pair of electrodes is working. In this exemplary use, the stimulating energy could be delivered before the balloon makes contact with tissue or after it makes contact with tissue, as blood generally has low enough impedance so as not to prevent the diagnostic test. In an alternative embodiment cardiac tissue can be stimulated while tissue is being ablated with other electrodes. For example without limitation, three electrodes could be used to deliver ablation energy to create a lesion between the three electrodes (e.g., a linear ablation), while an electrode on one side of the lesion could be used to deliver stimulating energy to an electrode on another side of the lesion to determine if the tissue is effectively ablated. Exemplary tissue stimulation delivery signal capabilities include currents of 0 to 20 ma, pulse widths of 0 to 100 ms, repetition rates of up to 300 bpm. More preferably 0 to 10 ma, 0 to 10 ms, and up to 180 bpm. Stimulating cardiac tissue in these ways is different than mapping in that mapping measures impedance, while stimulation delivers energy configured to stimulate the cardiac tissue. The disclosure herein therefore includes methods of stimulating cardiac tissue during an ablation procedure, including before the actual ablation, while ablating, or after the ablation has occurred.
One aspect of the disclosure is a method of superimposing an image or images provided by the camera with information or an image that is an indication of at least one of a characteristic of the cardiac tissue and a characteristic of the ablation catheter. The superimposed images (or superimposed information and image) are presented to the physician in a visual display, such as a monitor, and can be part of a remote user interface. The aspect includes methods and systems adapted to superimpose images. The methods and devices herein are also adapted to obtain the information and superimpose the images.
The information that is being superimposed can be any suitable visual indicator of a characteristic of the cardiac tissue or a characteristic of the ablation catheter.
In some embodiments the information that is superimposed onto the image from the cameras is the electrical activity on the cardiac tissue contacting the expandable member.
In some embodiments the information that is superimposed onto the image from the cameras is the localized impedance of the ablation circuit.
In some embodiments the information that is superimposed onto the image from the cameras is the temperature of the cardiac tissue opposed to the balloon.
In some embodiments the camera comprising CMOS cameras are adapted to be responsive to light in the infrared range. The response can be used to estimate the temperature of the tissue before, during and or after ablation. The response can be interpreted by an algorithm and displayed superimposed to the visual light image from the cameras.
In some embodiments an accelerometer is placed at a location in, on or near the ablation balloon. The accelerometer can be used to detect the orientation of the balloon in relation to gravity. The accelerometer can produce acceleration data that is used to determine the accelerometer position in relation to an initial position. The position can be used to construct a database of locations visited by the balloon and/or information collected by the electrodes on the balloon and/or RF power applied to the balloon electrodes. The collection of information can be used to reconstruct a model to provide guidance to the physician in relation to the locations that are treated and locations that need to be treated.
Superimposed information 406 provides a qualitative indication of tissue temperature, in this example, 99 degrees. Information 406 is next to the image of the electrode, whereas information 408 is information that is on the electrode image. Indicator 410 is a red color superimposed on top of the electrode, providing a qualitative indication of “hot.” Information 414 and 416 are superimposed to indicate that the respective electrodes are “on” and “off.”
In some embodiments the superimposed information is all the same type of information. For example, each electrode can, at the same time, be superimposed with information indicating the temperature of tissue. In other embodiments, the type of superimposed information can be different for any of the electrodes.
Additional examples of the type of information that can be superimposed include electrical impedance, which can be visualized quantitatively or qualitatively using any of the indicators herein (e.g., color, numbers). Additionally, mapping signals can be superimposed on the camera images as well.
The outline is that of the final ablation pads 102 (only the large square and the triangle). Apertures 103 are for saline flow. Circuit traces 104 terminate in exposed areas on the ablation pads. Conductive silver paint is used to create the ablation pad geometry and the exposed trace provides conductivity.
Alternately, a black adhesive may be used to darken the areas under silver painted ablation pads 102 to prevent reflections inside the balloon, as is described herein. One method of employing polyimide substrate 101 can eliminate the black adhesive providing a thinner and more compliant mounting surface.
A dielectric area 105 is provided to prevent cross talk and conductivity to the blood or other medium. The proximal side of the flex circuit has two small solder pads 106 where the wires are attached.
An assembled flexible circuit as represented in
Additionally an accelerometer 204 is placed at a location in, on or near the ablation balloon, such accelerometer can be used to detect the orientation of the balloon in relation to gravity and to construct treatment relevant data sets as described herein.
When the physician moves the catheters as described herein, more specifically, when the physician rotates the system around the longitudinal axis of the catheter, the image display will show the internal surface of the balloon fixed and everything outside the balloon (e.g., cardiac tissue) moving. This is due to the fact that the cameras, in the embodiments herein, are fixed in relation to the catheter and balloon system.
Disclosed here therefore is a system to, through image processing, show the internal surface of the balloon rotating while maintaining still, or fixed, the image of everything outside the balloon (e.g., tissue). In this manner, the image of everything that is not part of the catheter will remain fixed, and everything that is part of the catheter will be shown in the video to rotate. In this alternate embodiment, the image that the user views shows the fixed features (e.g., electrodes) being rotated while anatomical features remain still. The anatomical features are the non-fixed features or non-balloon related features in the tissue such as, represented in this view, the pulmonary vein, and the images of burns created by ablation. This is accomplished even though the fixed features move as the camera moves. Keeping the tissue fixed for the user, and having the device components move allows the physician to better control the movement of the device relative to the tissue. To facilitate this procedure the mean rotation of the center of mass of one or more of the key anatomical feature are calculated relative to the location of the fixed features. The mean or other suitable representation of the rotation(s) is then used to rotate the composite image as presented on the user display.
The number and arrangement of the electrodes disposed on the expandable member, each of which is individually addressable and can be used to deliver energy in either monopolar or bipolar mode, provides for a wide variety of lesion formations without having to remove and insert a separate RF catheter. The exemplary methods shown in
One of the advantages of the devices herein is that the number and arrangement of electrodes allow for a wide variety of lesion formations without removing and inserting a new catheter. And the visualization system allows for the entire procedure to be visualized.
One aspect of the disclosure is a delivery catheter comprising concentric sheaths as a steering mechanism with a mapping system built into the distal tip, where a mapping basket resides during delivery in the space between the two concentric shafts and on delivery is pushed forward out into the heart chamber. Examples of deployable mapping baskets are described above. An ablation catheter may then be delivered through the delivery catheter with the mapping basket in place. Target locations for ablation can then be identified using the electrodes on the mapping basket and target locations are then ablated with the ablation catheter. The location of the ablation catheter may in addition be identified and verified by the mapping basket.
One aspect of the disclosure is an ablation catheter that includes an electrode structure that is about 1 cm to about 5 cm in diameter and resides on the end of an inflatable or expandable structure and may comprise any of the following: an ablation catheter with a balloon carrying multiple electrodes. In some embodiments the multiple electrodes are used alternatively as a single ablation electrode then as a set of individual impedance sensing electrodes capable of monitoring the inter electrode impedance. Such measurements are useful in characterizing the efficacy of the burn resulting from the ablation and/or mapping the ablated are before or after the burn. In some embodiments contact pressure sensitive electrodes may be incorporated as a means of verifying appropriate contact of the electrode to the cardiac tissue. In many embodiments irrigation is provided as described elsewhere herein, wherein the irrigation system incorporates a pressure sensor. In such embodiments contact pressure may be inferred from changes in pressure within the irrigation system associated with increasing the outflow resistance at the irrigation outflow ports press against tissue. In other embodiments a balloon within a balloon configuration is used such that irrigation pressure may be isolated from inflation pressure. The change in pressure within the inflation system then is directly correlated to the contact pressure. In another alternative cooling may be provided by recirculation within the balloon as opposed to irrigation.
In some embodiments the contact pressure of an electrode is measured by impedance matching. An alternate means of characterizing the quality of lesions is to measure changes in acoustic impedance in the ultrasonic pass band. The acoustic impedance will be changed from that of normal tissue both as a function of temperature and denaturation. In such an embodiment a forward looking US transponder can be incorporated in the balloon or on the surface of the balloon. Such a sensor may be embodied as an array of one or more transponders, an array of one or more transmitters and an array of one or more receivers, or a single transponder.
In an alternate embodiment temperature of the lesion may be monitored by microwave radiometry.
A visual contact monitor comprised of a camera within the expandable structure monitors contact as a change in the visual appearance of transparent windows in the balloon. The changes in visual appearance result from differences in the appearance of blood and tissue.
Contact monitoring may be used control power delivery. Measurements of electrode contact obtained by any of the means described herein can be used to mediate the amount of power delivered to an electrode. One control algorithm limits power to an electrode such that the power per area of contact surface is maintained at a constant level.
The use of RF ablation in the treatment of atrial fibrillation as described herein poses the risk of thermal damage to the esophagus. This disclosure includes systems and methods to measure temperature of the esophageal wall during RF ablation. In some embodiments a balloon is placed in the esophagus and inflated to make contact with the esophageal wall. A pattern of temperature sensitive material deposited on the balloon measures the temperature change induced by RF ablation. An electronic circuit senses the temperature change to alert the operator.
A thermistor is a type of resistor whose resistance changes with temperature. A negative temperature thermistor (NTC) resistance decreases with temperature due to increased mobility of electrons and subsequent increased ability to conduct current. Commercial NTC thermistors are fabricated from common metal oxides of manganese, nickel, cobalt, iron, copper and titanium using basic ceramics technology. In the basic process, a mixture of a metal oxide powder and suitable binder are sintered in a suitable atmosphere and configuration to achieve the desired temperature coefficient characteristics.
Initial NTC thermistors were fabricated using silver sulfide (Ag2S) powder. More recently, miniaturized, planar silver ion-specific electrodes based on silver sulfide have been fabricated entirely by screen-printing using low-temperature curing polymer pastes and polyester substrates in the form of flexible foils (Sensors and Actuators B 96, 2003, 482-488). Ostensibly, in addition to sensing silver ions, such constructions may also be sensitive to temperature.
A pattern of temperature-sensitive material is deposited on a flexible balloon which is sized to occlude the esophagus. The pattern includes two flexible thermistors (flextors). The two flextors are used in a battery-powered Wheatstone bridge electrical circuit to measure the differential temperature of the two flextors. When placed in the esophagus, the differential temperature induced by RF heating is sensed. If a temperature differential exceeds a limit, the circuit alerts the operator to modify the RF ablation treatment.
The expandable member, which in some embodiments can be an electrode assembly, can be sheathed using a sheathing fixture 103 and introduced into a sheath that is placed at the appropriate entry point, the femoral vein for example (see
An alternate way of sheathing prior to introduction to the introducer is illustrated in
In yet another embodiment a sheathing tube may or may not be required. This embodiment is represented in
The assembly 105 can be delivered to the left atrium and the membrane expanded and placed at the antrum of one of the pulmonary veins. The overall shape of the membrane can be visualized using the electrodes themselves as the conductive metallic material of the electrodes can provide visualization under fluoroscopy. The radiopaque markers can be used to determine exact location of each electrode based on the marker orientation. The mapping electrodes can be used to measure initial electrical signals and can later confirm electrical conduction block post ablation. The user can select which electrodes to turn on, which ones to leave off, and which ones to set to a higher or lower power setting based on their contact with the tissue. The various methods of contact detection as described above, or a fiber optic, can be used to confirm contact of the electrodes with the tissue. The device is then set to the appropriate power and temperature settings, irrigation turned on to the desired level, and energy transmission initiated. The mapping electrodes can be used now to determine successful conduction block. Once conduction block is achieved, the catheter and moved over to the next target location, another pulmonary vein or atrial wall, for ablation.
In
Cooling procedures, either by direct irrigation at or near the electrodes or circulating cooling fluids through the expandable structure, are especially useful when the target tissue is not at the surface to which the electrodes are in closest proximity, but deeper into the adjoining tissue. Cooling the expandable structure or the irrigation fluid can allow for higher energy delivery while protecting the tissue near or in contact with the expandable structure while still allowing damage to tissue further away from the electrode. One such embodiment which allows for irrigation is shown in
In this embodiment, tool 120 is similar in some ways to the other expandable members described herein. Tool 120 includes an expandable balloon 125, one or more flexible circuits 123 carried by balloon 125, and a plurality of electrodes 124p and 124d carried directly or indirectly by balloon 125. Electrodes 124d and electrodes 124p include longitudinally aligned distal electrodes 124d and longitudinally aligned proximal electrodes 124p. Longitudinally (or axially) aligned as used herein means that at least two things have distal ends that in are disposed in a plane and proximal ends that are disposed in a plane, the planes orthogonal to a longitudinal axis of the device. In other embodiments, only one of the distal ends and proximal ends may be disposed in a plane. In the embodiment in
In the embodiment in
Tool 120 also includes a plurality of irrigation apertures 122, which in this embodiment extend through the electrodes and the balloon. In this embodiment, each electrode has an irrigation aperture 122 therethrough.
In some embodiments the greatest radial dimension “Y” (see
In a side view, the pairs of lenses in each subassembly 413 and 414 are axially aligned (in planes normal to the orthogonal to the longitudinal axis). The lenses in different subassemblies are axially spaced at fixed distances.
Visualization system 400 also includes housing 415, which houses the components of the camera system 410. Housing 415 can be machined and/or molded, for example, and the other components (e.g., lenses and sensors) can then be secured to housing 415.
Visualization system 400 also includes illumination assembly 420, which is disposed proximal to the camera system 410. The illumination assembly 420 includes a plurality of light sources (e.g., LEDs) 421 (only one light source is labeled for clarity) disposed around the illumination assembly 420. In some embodiments lighting flex circuit 423, which carries the electronics for the lighting assembly 420, is secured to the illumination assembly 420, as shown. Illumination assembly 420 is disposed such that light from the light sources is emitted at diffuser 430, as is described above.
Visualization system 400 also includes optional temperature sensor 422.
Housing 415 includes lumen 417 extending therethrough, through which guidewire lumen 234 (see
The energy delivery device also includes external device 200 that can be in the form of a handle. In this embodiment in
Actuator 231 can include an expandable member control grip 232, a slider 233 riding on one or more slides 235, the slider affixed to a guide wire lumen 234 (see
The energy delivery device can also include an electrical interface 250 (see
In some embodiments the energy delivery device has the following characteristics: effective length: 70 cm; the steerable section a deflection angle: 0-120 deg, or −60 to +60; max actuation displacement: 30 mm; a maximum length change when steering is fully actuated: ˜3 mm.
Elongate member or finger 523a includes a substrate layer, three discrete elongate conductor layers 528D, 528M, and 528P extending along the elongate member. Conductor layers 528D and 528P are in electrical communication with distal electrode 526 and proximal electrode 525 at regions 529D and 52P, respectively. The electrical communication regions 529D and 529P can be formed as described above with reference to
The distal electrodes have a generally triangular configuration, tapering towards the distal end. The proximal electrodes have a generally rectangular configuration.
The flexible circuits also include identification markers 534, which can be visualized and aid in identification the location of the electrodes. In this embodiment, markers 534 are disposed between the substrate layer and the balloon layer, adhered to the substrate. They are disposed such that they overlap with a distal region of the electrodes. Gold is an example of the material of markers that can enable visualization. The distance between, location, number, and arrangement of markers may be varied to identify each arm marked.
Elongate members 523 can optionally include one or more adhesive aperture 535, to improve adhesion of the substrate to the balloon.
The regions of the substrate layer that are under the proximal and distal electrodes include a plurality of projections 536 (also referred to as protrusions) that extend outward from the sides of the substrate. These projections improve the adhesion between the balloon and the substrate, as an adhesive 559 can occupy the spaces between the projections. In some embodiments, regions of the substrate that are not under the electrodes may include the projections.
A substrate can include one or more projections 536, and they can extend from one or both sides. The projections shown are regularly spaced apart, but need not be. The projections in this embodiment extend slightly in the distal direction (i.e., not orthogonally and not proximally) to reduce the risk of catching the projections on the delivery catheter during sheathing, but in other embodiments may extend in other direction. By saying that they extend in the distal direction, the projections are not orthogonal to the longitudinal axis of the arms. The projections can have other configurations as well.
The protrusions in this embodiment have the same configuration, but the configurations may vary. At least 50% of the plurality of protrusions have the same general configuration.
The protrusions can have a width 515 from 0.001 inch to 0.5 inches, such as from 0.001 inch to 0.25 inches, such as from 0.001 inch to 0.1 inch, such as from 0.001 inch to 0.01 inches, such as 0.001 inch to 0.007 inches (this is the shorter of the dimensions in the embodiment in
In this embodiment each elongate member 523 includes three conductors, each terminating at an interconnect pad 531 at a proximal end. In this embodiment conductor 528P terminates at pad 531P, conductor 528M terminates at pad 531M, and conductor 528D terminates at pad 531D. The pads 531D, M, and P are not aligned longitudinally (i.e., axially), to reduce the radial footprint of the proximal pad region. The pads are in electrical communication with additional conductors that carry the electrical signals to the proximal end of the energy delivery device. For example, the additional conductors can extend along a shaft of the energy delivery device.
As can be seen in
In alternate embodiments of a multi-piece flex-circuit array, each element may have a central hub with elongate members extending in both (e.g., opposite) directions. Each element can then be stacked with the central hub aligning with the guide wire lumen. For example, in the embodiment in
It may be advantageous during cardiac intervention to have available to the operator a compact-size version of any of the embodiments described herein. The system may provide the user with a one-shot style energy delivery device well suited for, but not limited to, single-point ablation touch-ups within the cardiac chamber, for example. This possible alternate embodiment of the disclosure may comprise a relatively small balloon in a compact design with a plurality of flexible circuits comprising elastomeric electrodes and optional mapping sensors extending proximally to distally along the exterior surface of the balloon and affixed to low-profile flexible circuits. The device can also include, within the expandable member, one or more imaging and illumination components similar to any of the systems described herein. The compact tool design may allow for greater maneuverability in small spaces and may offer a steerable portion integrated into an attached catheter.
In this exemplary embodiment, the elastomeric electrodes 5824 are spaced 90 degrees apart around the balloon, and are longer than they are wide, extending over both the distal and proximal portions of the balloon.
Energy delivery device 5800 may also comprise a visualization system 5840 disposed proximally within the balloon. Visualization system 5840 can include camera system 5833 and a plurality of light sources 5835 (e.g., LEDs). Camera system 5833 may comprise a single camera or a plurality of cameras, and a single camera configuration is shown in
In this embodiment the irrigation fluid (which inflates the balloon) passes through an irrigation lumen within the catheter and over the plurality of light sources 5835 (e.g., LEDs). The irrigation fluid can cool the light sources as is flows past the light sources and into the balloon. This provides an added benefit of preventing the light sources from overheating during use. In some embodiments the powering of the illumination elements is synchronized with the delivery of irrigation fluid such that illumination is only performed while irrigation is performed. In addition or other embodiments irrigation is served to illumination element temperature.
Compact tools 5820 and 6020 may comprise one or more elongate members 5822 shown in
In the embodiments in
One of the benefits of some of the embodiments herein is that it is possible to get a complete burn in tissue between any adjacent electrodes, when operating in bipolar mode. This allows any two adjacent electrodes to be operated in bipolar mode and effectively ablate tissue between those electrodes. This creates a significant advantage when in use, as it increases the physician's options for ablating the desired tissue region.
One of the aspects of the device that allows complete burns to be reliably created between adjacent electrodes is the power density of the device when in use. “Power density” as used herein refers to power per area, either with respect to surface area of one or more electrodes, or surface area of one or more electrodes and surface area of the balloon in between adjacent electrodes.
The disclosure below provides a quantitative assessment for power density in an exemplary use of the device shown in
In an exemplary method of use, the power delivered per electrode for full electrode contact was 8 W, and the power delivered per electrode for partial electrode contact was 10 W. Table 2 below illustrates power densities calculated based on surface areas of the inner electrodes 652 being 0.272 cm2, outer electrodes 660 having surface areas of 0.273 cm2, spacing area 656 between inner electrodes to be 0.221 cm2, spacing area 664 between outer electrodes to be 0.288 cm2. Power density is calculated as power/area.
The thickness of the atrial wall is about 1 mm to 10 mm, generally 1 mm to 3 mm. The average power density across the thickness of the heart can thus be calculated using any of the powers described herein and the area that defined by the heart thickness and the width of the tissue through which the energy is passing. The width of the tissue through which the energy is passing is generally the same as the length of the electrode, or the length of electrode sides that are facing each other, any of which described herein can be used to calculate the power densities.
Table 3 and the analysis below illustrates some alternative devices, illustrating how devices with smaller electrode areas results in much higher power densities that than when the current device is used with somewhat similar power inputs. Using the data from Table 3, the device labeled “4 mm Tip” has a power density of about 90 W/cm2 when the power input is 30 W. The PVAC devices has a power density of about 147 W/cm2 when a max 10 W power is used. The MASC and MAAC have power densities of about 220 W/cm2 when a max 10 W power is used.
The disclosure provides methods of use that include power densities of less than about 40 W/cm2, when calculated based on the surface area of a particular electrode, and when there is full contact between the electrode and tissue. The disclosure provides methods of use that include power densities of less than about 25 W/cm2, when calculated based on the surface area spanning two electrodes and the spacing between them.
This application is a continuation of International Application PCT/US2016/062323, with an international filing date of Nov. 16, 2016, which claims priority to the following U.S. Provisional Applications: 62/255,895, filed Nov. 16, 2015; 62/259,596, filed Nov. 24, 2015; 62/309,359, filed Mar. 16, 2016; and 62/326,546, filed Apr. 22, 2016. All of the aforementioned applications are incorporated by reference herein. This application incorporates by reference herein the disclosures of the following: U.S. Pat. Nos. 8,295,902; 8,805,466; and U.S. Pub. No. 2014/0357956.
Number | Name | Date | Kind |
---|---|---|---|
4448188 | Loeb | May 1984 | A |
4547193 | Rydell | Oct 1985 | A |
4602281 | Nagasaki et al. | Jul 1986 | A |
4611888 | Prenovitz et al. | Sep 1986 | A |
4633879 | Ong | Jan 1987 | A |
4634432 | Kocak | Jan 1987 | A |
4638207 | Radice | Jan 1987 | A |
4646721 | Arakawa | Mar 1987 | A |
4692139 | Stiles | Sep 1987 | A |
4726382 | Boehmer et al. | Feb 1988 | A |
4739766 | Riederer | Apr 1988 | A |
4784133 | Mackin | Nov 1988 | A |
4809680 | Yabe | Mar 1989 | A |
4827907 | Tashiro | May 1989 | A |
4832003 | Yabe | May 1989 | A |
4843275 | Radice | Jun 1989 | A |
4890623 | Cook et al. | Jan 1990 | A |
4961738 | Mackin | Oct 1990 | A |
4968306 | Huss et al. | Nov 1990 | A |
5010895 | Maurer et al. | Apr 1991 | A |
5029574 | Shimamura et al. | Jul 1991 | A |
5041089 | Mueller et al. | Aug 1991 | A |
5069674 | Fearnot et al. | Dec 1991 | A |
5090959 | Samson et al. | Feb 1992 | A |
5109861 | Walinsky et al. | May 1992 | A |
5115472 | Park et al. | May 1992 | A |
5135001 | Sinofsky et al. | Aug 1992 | A |
5180376 | Fischell | Jan 1993 | A |
5187572 | Nakamura et al. | Feb 1993 | A |
5209741 | Spaeth | May 1993 | A |
5213576 | Abiuso et al. | May 1993 | A |
5228442 | Imran | Jul 1993 | A |
5233416 | Inoue | Aug 1993 | A |
5301090 | Hed | Apr 1994 | A |
5306250 | March et al. | Apr 1994 | A |
5309910 | Edwards et al. | May 1994 | A |
5311866 | Kagan et al. | May 1994 | A |
5325847 | Matsuno | Jul 1994 | A |
5343860 | Metzger et al. | Sep 1994 | A |
5377682 | Ueno et al. | Jan 1995 | A |
5385148 | Lesh et al. | Jan 1995 | A |
5391200 | KenKnight et al. | Feb 1995 | A |
5409000 | Imran | Apr 1995 | A |
5411016 | Kume et al. | May 1995 | A |
5430475 | Goto et al. | Jul 1995 | A |
5443470 | Stern et al. | Aug 1995 | A |
5494483 | Adair | Feb 1996 | A |
5505730 | Edwards | Apr 1996 | A |
5515843 | Chang | May 1996 | A |
5515848 | Corbett, III et al. | May 1996 | A |
5524338 | Martyniuk et al. | Jun 1996 | A |
5540679 | Fram et al. | Jul 1996 | A |
5558672 | Edwards et al. | Sep 1996 | A |
5562720 | Stern et al. | Oct 1996 | A |
5569241 | Edwards | Oct 1996 | A |
5571086 | Kaplan et al. | Nov 1996 | A |
5571088 | Lennox et al. | Nov 1996 | A |
5573520 | Schwartz et al. | Nov 1996 | A |
5575772 | Lennox | Nov 1996 | A |
5575788 | Baker et al. | Nov 1996 | A |
5594497 | Ahern et al. | Jan 1997 | A |
5607436 | Pratt et al. | Mar 1997 | A |
5609574 | Kaplan et al. | Mar 1997 | A |
5609606 | O'Boyle | Mar 1997 | A |
5611807 | O'Boyle | Mar 1997 | A |
5626564 | Zhan et al. | May 1997 | A |
5630837 | Crowley | May 1997 | A |
5681308 | Edwards et al. | Oct 1997 | A |
5715825 | Crowley | Feb 1998 | A |
5718701 | Shai et al. | Feb 1998 | A |
5722403 | McGee et al. | Mar 1998 | A |
5735846 | Panescu et al. | Apr 1998 | A |
5769846 | Edwards et al. | Jun 1998 | A |
5769880 | Truckai et al. | Jun 1998 | A |
5779698 | Clayman et al. | Jul 1998 | A |
5795325 | Valley et al. | Aug 1998 | A |
5797837 | Minami | Aug 1998 | A |
5800408 | Strauss et al. | Sep 1998 | A |
5827273 | Edwards | Oct 1998 | A |
5830213 | Panescu et al. | Nov 1998 | A |
5836874 | Swanson et al. | Nov 1998 | A |
5846196 | Siekmeyer et al. | Dec 1998 | A |
5846238 | Jackson et al. | Dec 1998 | A |
5846239 | Swanson et al. | Dec 1998 | A |
5853411 | Whayne et al. | Dec 1998 | A |
5860974 | Abele | Jan 1999 | A |
5871483 | Jackson et al. | Feb 1999 | A |
5879348 | Owens et al. | Mar 1999 | A |
5881727 | Edwards | Mar 1999 | A |
5888577 | Griffin, III et al. | Mar 1999 | A |
5904651 | Swanson et al. | May 1999 | A |
5916213 | Haissaguerre et al. | Jun 1999 | A |
5935075 | Casscells et al. | Aug 1999 | A |
5938660 | Swartz et al. | Aug 1999 | A |
5940126 | Kimura | Aug 1999 | A |
5957950 | Mockros et al. | Sep 1999 | A |
5961513 | Swanson et al. | Oct 1999 | A |
5967986 | Cimochowski et al. | Oct 1999 | A |
5984860 | Shan | Nov 1999 | A |
5991650 | Swanson et al. | Nov 1999 | A |
5997571 | Farr et al. | Dec 1999 | A |
6004269 | Crowley et al. | Dec 1999 | A |
6006119 | Soller et al. | Dec 1999 | A |
6012457 | Lesh | Jan 2000 | A |
6024740 | Lesh et al. | Feb 2000 | A |
6052607 | Edwards et al. | Apr 2000 | A |
6071302 | Sinofsky et al. | Jun 2000 | A |
6102905 | Baxter et al. | Aug 2000 | A |
6117101 | Diederich et al. | Sep 2000 | A |
6123718 | Tu et al. | Sep 2000 | A |
6124883 | Suzuki et al. | Sep 2000 | A |
6134463 | Wittkampf et al. | Oct 2000 | A |
6142993 | Whayne et al. | Nov 2000 | A |
6159203 | Sinofsky | Dec 2000 | A |
6163726 | Wolf | Dec 2000 | A |
6164283 | Lesh | Dec 2000 | A |
6168591 | Sinofsky | Jan 2001 | B1 |
6178346 | Amundson et al. | Jan 2001 | B1 |
6205361 | Kuzma et al. | Mar 2001 | B1 |
6206912 | Goldsteen et al. | Mar 2001 | B1 |
6215231 | Newnham et al. | Apr 2001 | B1 |
6231516 | Keilman et al. | May 2001 | B1 |
6233491 | Kordis et al. | May 2001 | B1 |
6258087 | Edwards et al. | Jul 2001 | B1 |
6270492 | Sinofsky | Aug 2001 | B1 |
6292689 | Wallace et al. | Sep 2001 | B1 |
6315712 | Rovegno | Nov 2001 | B1 |
6375654 | McIntyre | Apr 2002 | B1 |
6384915 | Everett et al. | May 2002 | B1 |
6391024 | Sun et al. | May 2002 | B1 |
6402746 | Whayne et al. | Jun 2002 | B1 |
6416463 | Tsuzuki et al. | Jul 2002 | B1 |
6425877 | Edwards | Jul 2002 | B1 |
6460545 | Kordis | Oct 2002 | B2 |
6485414 | Neuberger | Nov 2002 | B1 |
6500174 | Maguire et al. | Dec 2002 | B1 |
6511478 | Burnside et al. | Jan 2003 | B1 |
6514249 | Maguire et al. | Feb 2003 | B1 |
6517534 | McGovern et al. | Feb 2003 | B1 |
6527769 | Langberg et al. | Mar 2003 | B2 |
6558375 | Sinofsky et al. | May 2003 | B1 |
6558378 | Sherman et al. | May 2003 | B2 |
6572609 | Farr et al. | Jun 2003 | B1 |
6572612 | Stewart et al. | Jun 2003 | B2 |
6579285 | Sinofsky | Jun 2003 | B2 |
6595989 | Schaer | Jul 2003 | B1 |
6599288 | Maguire et al. | Jul 2003 | B2 |
6605055 | Sinofsky et al. | Aug 2003 | B1 |
6605084 | Acker et al. | Aug 2003 | B2 |
6607502 | Maguire et al. | Aug 2003 | B1 |
6635027 | Cragg et al. | Oct 2003 | B1 |
6635054 | Fjield et al. | Oct 2003 | B2 |
6641553 | Chee et al. | Nov 2003 | B1 |
6652515 | Maguire et al. | Nov 2003 | B1 |
6659940 | Adler | Dec 2003 | B2 |
6659953 | Smanaweera et al. | Dec 2003 | B1 |
6660002 | Edwards et al. | Dec 2003 | B1 |
6676656 | Sinofsky | Jan 2004 | B2 |
6692430 | Adler | Feb 2004 | B2 |
6692431 | Kazakevich | Feb 2004 | B2 |
6692455 | Goode et al. | Feb 2004 | B2 |
6692461 | Wantink | Feb 2004 | B2 |
6692462 | Mackenzie et al. | Feb 2004 | B2 |
6692463 | Marteau et al. | Feb 2004 | B1 |
6692464 | Graf | Feb 2004 | B2 |
6692490 | Edwards | Feb 2004 | B1 |
6702782 | Miller et al. | Mar 2004 | B2 |
6736811 | Panescu et al. | May 2004 | B2 |
6743226 | Cosman et al. | Jun 2004 | B2 |
6752805 | Maguire et al. | Jun 2004 | B2 |
6771996 | Bowe et al. | Aug 2004 | B2 |
6780183 | Jimenez, Jr. et al. | Aug 2004 | B2 |
6808524 | Lopath et al. | Oct 2004 | B2 |
6814730 | Li | Nov 2004 | B2 |
6869431 | Maguire et al. | Mar 2005 | B2 |
6872183 | Sampson et al. | Mar 2005 | B2 |
6872206 | Edwards et al. | Mar 2005 | B2 |
6887235 | O'Connor et al. | May 2005 | B2 |
6911027 | Edwards et al. | Jun 2005 | B1 |
6932809 | Sinofsky | Aug 2005 | B2 |
6937899 | Sheldon et al. | Aug 2005 | B2 |
6942657 | Sinofsky et al. | Sep 2005 | B2 |
6949072 | Furnish et al. | Sep 2005 | B2 |
6955173 | Lesh | Oct 2005 | B2 |
6976956 | Takahashi et al. | Dec 2005 | B2 |
6978174 | Gelfand et al. | Dec 2005 | B2 |
7004923 | Deniega et al. | Feb 2006 | B2 |
7030904 | Adair et al. | Apr 2006 | B2 |
7048733 | Hartley et al. | May 2006 | B2 |
7115122 | Swanson et al. | Oct 2006 | B1 |
7137395 | Fried et al. | Nov 2006 | B2 |
7150745 | Stern et al. | Dec 2006 | B2 |
7162303 | Levin et al. | Jan 2007 | B2 |
7166075 | Varghese et al. | Jan 2007 | B2 |
7169140 | Kume | Jan 2007 | B1 |
7207984 | Farr et al. | Apr 2007 | B2 |
7226448 | Bertolero et al. | Jun 2007 | B2 |
7232437 | Berman et al. | Jun 2007 | B2 |
7238179 | Brucker et al. | Jul 2007 | B2 |
7238180 | Mester et al. | Jul 2007 | B2 |
7267674 | Brucker et al. | Sep 2007 | B2 |
7285116 | de la Rama et al. | Oct 2007 | B2 |
7286866 | Okerlund et al. | Oct 2007 | B2 |
7291146 | Steinke | Nov 2007 | B2 |
7293562 | Malecki et al. | Nov 2007 | B2 |
7300397 | Adler et al. | Nov 2007 | B2 |
7310150 | Guillermo et al. | Dec 2007 | B2 |
7320677 | Brouillette | Jan 2008 | B2 |
7344533 | Pearson et al. | Mar 2008 | B2 |
7346381 | Okerlund et al. | Mar 2008 | B2 |
7357796 | Farr et al. | Apr 2008 | B2 |
7365859 | Yun et al. | Apr 2008 | B2 |
7366376 | Shishkov et al. | Apr 2008 | B2 |
7367975 | Maiecki et al. | May 2008 | B2 |
7371231 | Rioux et al. | May 2008 | B2 |
7382949 | Bouma et al. | Jun 2008 | B2 |
7396355 | Goldman et al. | Jul 2008 | B2 |
7406970 | Zikorus et al. | Aug 2008 | B2 |
7413568 | Swanson et al. | Aug 2008 | B2 |
7418169 | Tearney et al. | Aug 2008 | B2 |
7427265 | Keilman et al. | Sep 2008 | B1 |
7429260 | Underwood et al. | Sep 2008 | B2 |
7429261 | Kunis et al. | Sep 2008 | B2 |
7445618 | Eggers et al. | Nov 2008 | B2 |
7447408 | Bouma et al. | Nov 2008 | B2 |
7452358 | Stern et al. | Nov 2008 | B2 |
7468062 | Oral et al. | Dec 2008 | B2 |
7473251 | Knowlton et al. | Jan 2009 | B2 |
7481808 | Koyfman et al. | Jan 2009 | B2 |
7481809 | Stern et al. | Jan 2009 | B2 |
7489969 | Knudson et al. | Feb 2009 | B2 |
7507236 | Eggers et al. | Mar 2009 | B2 |
7510555 | Kanzius | Mar 2009 | B2 |
7517346 | Sloan et al. | Apr 2009 | B2 |
7519096 | Bouma et al. | Apr 2009 | B2 |
7529393 | Peszynski et al. | May 2009 | B2 |
7534204 | Starksen et al. | May 2009 | B2 |
7538859 | Tearney et al. | May 2009 | B2 |
7585273 | Adler et al. | Sep 2009 | B2 |
7588535 | Adler et al. | Sep 2009 | B2 |
7617005 | Demarais et al. | Nov 2009 | B2 |
7620451 | Demarais et al. | Nov 2009 | B2 |
7653438 | Deem et al. | Jan 2010 | B2 |
7669309 | Johnson et al. | Mar 2010 | B2 |
7683323 | Kymissis | Mar 2010 | B2 |
7756583 | Demarais et al. | Jul 2010 | B2 |
7758499 | Adler | Jul 2010 | B2 |
7853333 | Demarais | Dec 2010 | B2 |
7879029 | Jimenez | Feb 2011 | B2 |
7928113 | Neamati et al. | Apr 2011 | B2 |
7935108 | Baxter et al. | May 2011 | B2 |
7937143 | Demarais et al. | May 2011 | B2 |
7951144 | Mahajan | May 2011 | B2 |
8007440 | Magnin et al. | Aug 2011 | B2 |
8025661 | Arnold et al. | Sep 2011 | B2 |
8078266 | Saadat et al. | Dec 2011 | B2 |
8167805 | Emery et al. | May 2012 | B2 |
8172747 | Wallace et al. | May 2012 | B2 |
8194121 | Blumzvig et al. | Jun 2012 | B2 |
8295902 | Salahieh et al. | Oct 2012 | B2 |
8323241 | Salahieh et al. | Dec 2012 | B2 |
8333012 | Rothe et al. | Dec 2012 | B2 |
8337492 | Kunis et al. | Dec 2012 | B2 |
8361041 | Fang et al. | Jan 2013 | B2 |
8369921 | Tegg et al. | Feb 2013 | B2 |
8417321 | Saadat et al. | Apr 2013 | B2 |
8419613 | Saadat et al. | Apr 2013 | B2 |
8465421 | Finkman et al. | Jun 2013 | B2 |
8479585 | Shaw-Klein | Jul 2013 | B2 |
8540704 | Melsky et al. | Sep 2013 | B2 |
8560086 | Just et al. | Oct 2013 | B2 |
8617150 | Tsoref et al. | Dec 2013 | B2 |
8702682 | Atanasoska et al. | Apr 2014 | B2 |
8708953 | Salahieh et al. | Apr 2014 | B2 |
8728073 | McDaniel | May 2014 | B2 |
8777857 | Sliwa et al. | Jul 2014 | B2 |
8805466 | Salahieh et al. | Aug 2014 | B2 |
8808281 | Emmons et al. | Aug 2014 | B2 |
8840601 | Salahieh et al. | Sep 2014 | B2 |
8894643 | Watson et al. | Nov 2014 | B2 |
8920369 | Salahieh et al. | Dec 2014 | B2 |
8939970 | Stone et al. | Jan 2015 | B2 |
8968591 | Nishikubo et al. | Mar 2015 | B2 |
8981625 | Nishikubo et al. | Mar 2015 | B2 |
9037259 | Mathur | May 2015 | B2 |
9174050 | Mathur et al. | Nov 2015 | B2 |
9333031 | Salahieh et al. | May 2016 | B2 |
9445862 | Brewster et al. | Sep 2016 | B2 |
9586025 | Salahieh et al. | Mar 2017 | B2 |
9610006 | Salahieh et al. | Apr 2017 | B2 |
9655677 | Salahieh et al. | May 2017 | B2 |
9717557 | Salahieh et al. | Aug 2017 | B2 |
20020002384 | Gilson et al. | Jan 2002 | A1 |
20020068934 | Edwards et al. | Jun 2002 | A1 |
20020087208 | Koblish et al. | Jul 2002 | A1 |
20020095147 | Shadduck | Jul 2002 | A1 |
20020111548 | Swanson et al. | Aug 2002 | A1 |
20020154215 | Schechterman et al. | Oct 2002 | A1 |
20020165535 | Lesh et al. | Nov 2002 | A1 |
20020183623 | Tang et al. | Dec 2002 | A1 |
20030050637 | Maguire et al. | Mar 2003 | A1 |
20030065371 | Satake | Apr 2003 | A1 |
20030097121 | Jolly et al. | May 2003 | A1 |
20030097129 | Davison et al. | May 2003 | A1 |
20030135101 | Webler | Jul 2003 | A1 |
20030233099 | Danaek et al. | Dec 2003 | A1 |
20030236443 | Cespedes et al. | Dec 2003 | A1 |
20040054363 | Vaska et al. | Mar 2004 | A1 |
20040147911 | Sinofsky | Jul 2004 | A1 |
20040147912 | Sinofsky | Jul 2004 | A1 |
20040147913 | Sinofsky | Jul 2004 | A1 |
20040167503 | Sinofsky | Aug 2004 | A1 |
20040243118 | Ayers et al. | Dec 2004 | A1 |
20050004440 | Vanney | Jan 2005 | A1 |
20050065504 | Melsky et al. | Mar 2005 | A1 |
20050171527 | Bhola | Aug 2005 | A1 |
20050203597 | Yamazaki et al. | Sep 2005 | A1 |
20050222558 | Baxter et al. | Oct 2005 | A1 |
20050234436 | Baxter et al. | Oct 2005 | A1 |
20050234437 | Baxter et al. | Oct 2005 | A1 |
20050245892 | Elkins et al. | Nov 2005 | A1 |
20060041277 | Deem et al. | Feb 2006 | A1 |
20060089632 | Barthe et al. | Apr 2006 | A1 |
20060100618 | Chan et al. | May 2006 | A1 |
20060173300 | Oslund et al. | Aug 2006 | A1 |
20060206150 | Demarais et al. | Sep 2006 | A1 |
20060212076 | Demarais et al. | Sep 2006 | A1 |
20060212078 | Demarais et al. | Sep 2006 | A1 |
20060241589 | Heim et al. | Oct 2006 | A1 |
20060247701 | Zacouto | Nov 2006 | A1 |
20060265014 | Demarais et al. | Nov 2006 | A1 |
20060265015 | Demarais et al. | Nov 2006 | A1 |
20060271111 | Demarais et al. | Nov 2006 | A1 |
20060276852 | Demarais et al. | Dec 2006 | A1 |
20070032727 | Omata | Feb 2007 | A1 |
20070073135 | Lee et al. | Mar 2007 | A1 |
20070078507 | Zacouto | Apr 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070118094 | Bingham et al. | May 2007 | A1 |
20070129720 | Demarais et al. | Jun 2007 | A1 |
20070129760 | Demarais et al. | Jun 2007 | A1 |
20070135875 | Demarais et al. | Jun 2007 | A1 |
20070213616 | Anderson et al. | Sep 2007 | A1 |
20070213671 | Hiatt | Sep 2007 | A1 |
20070219451 | Kula et al. | Sep 2007 | A1 |
20070225634 | Ferren et al. | Sep 2007 | A1 |
20070233185 | Anderson et al. | Oct 2007 | A1 |
20070244501 | Horn et al. | Oct 2007 | A1 |
20070255097 | Jung et al. | Nov 2007 | A1 |
20070270686 | Ritter et al. | Nov 2007 | A1 |
20070287994 | Patel | Dec 2007 | A1 |
20080004652 | Abboud et al. | Jan 2008 | A1 |
20080058590 | Saadat et al. | Mar 2008 | A1 |
20080058591 | Saadat et al. | Mar 2008 | A1 |
20080058836 | Moll et al. | Mar 2008 | A1 |
20080071173 | Aldrich | Mar 2008 | A1 |
20080108867 | Zhou | May 2008 | A1 |
20080125772 | Stone et al. | May 2008 | A1 |
20080188912 | Stone et al. | Aug 2008 | A1 |
20080205481 | Faries, Jr. et al. | Aug 2008 | A1 |
20080262489 | Steinke | Oct 2008 | A1 |
20080275300 | Rothe et al. | Nov 2008 | A1 |
20080275445 | Kelly et al. | Nov 2008 | A1 |
20080281293 | Peh et al. | Nov 2008 | A1 |
20080281312 | Werneth et al. | Nov 2008 | A1 |
20080281322 | Sherman et al. | Nov 2008 | A1 |
20080296152 | Voss | Dec 2008 | A1 |
20090024195 | Rezai et al. | Jan 2009 | A1 |
20090030276 | Saadat et al. | Jan 2009 | A1 |
20090030412 | Willis et al. | Jan 2009 | A1 |
20090046171 | Kogan | Feb 2009 | A1 |
20090051763 | Adler et al. | Feb 2009 | A1 |
20090054786 | Beckermus | Feb 2009 | A1 |
20090054787 | Adler et al. | Feb 2009 | A1 |
20090054803 | Saadat et al. | Feb 2009 | A1 |
20090076498 | Saadat et al. | Mar 2009 | A1 |
20090125022 | Saadat et al. | May 2009 | A1 |
20090137893 | Seibel et al. | May 2009 | A1 |
20090203962 | Miller et al. | Aug 2009 | A1 |
20090227885 | Lowery et al. | Sep 2009 | A1 |
20090227999 | Willis et al. | Sep 2009 | A1 |
20090240249 | Chan et al. | Sep 2009 | A1 |
20090247933 | Maor et al. | Oct 2009 | A1 |
20090254142 | Edwards et al. | Oct 2009 | A1 |
20090275799 | Saadat et al. | Nov 2009 | A1 |
20090299354 | Melsky et al. | Dec 2009 | A1 |
20090312754 | Lenihan et al. | Dec 2009 | A1 |
20090318757 | Singh | Dec 2009 | A1 |
20090318759 | Jacobsen et al. | Dec 2009 | A1 |
20090326320 | Sinofsky et al. | Dec 2009 | A1 |
20090326321 | Jacobsen et al. | Dec 2009 | A1 |
20090326572 | Peh et al. | Dec 2009 | A1 |
20100016957 | Jager et al. | Jan 2010 | A1 |
20100087782 | Ghaffari et al. | Apr 2010 | A1 |
20100121142 | Ouyang et al. | May 2010 | A1 |
20100204560 | Salahieh et al. | Aug 2010 | A1 |
20100204561 | Saadat et al. | Aug 2010 | A1 |
20100238279 | Thoms et al. | Sep 2010 | A1 |
20110034790 | Mourlas et al. | Feb 2011 | A1 |
20110034912 | de Graff et al. | Feb 2011 | A1 |
20110040172 | Carpentier et al. | Feb 2011 | A1 |
20110046600 | Crank | Feb 2011 | A1 |
20110077579 | Harrison et al. | Mar 2011 | A1 |
20110082449 | Melsky et al. | Apr 2011 | A1 |
20110082450 | Melsky et al. | Apr 2011 | A1 |
20110082451 | Melsky | Apr 2011 | A1 |
20110082452 | Melsky et al. | Apr 2011 | A1 |
20110152352 | Hata et al. | Jun 2011 | A1 |
20110160514 | Long et al. | Jun 2011 | A1 |
20110160584 | Paul et al. | Jun 2011 | A1 |
20110201973 | Stephens et al. | Aug 2011 | A1 |
20110237940 | Raleigh | Sep 2011 | A1 |
20110257523 | Hastings et al. | Oct 2011 | A1 |
20110292258 | Adler et al. | Dec 2011 | A1 |
20110301418 | Gharib et al. | Dec 2011 | A1 |
20110319752 | Steinberg et al. | Dec 2011 | A1 |
20120004529 | Tolkowsky et al. | Jan 2012 | A1 |
20120004537 | Tolkowsky et al. | Jan 2012 | A1 |
20120069367 | Iguchi | Mar 2012 | A1 |
20120071870 | Salahieh | Mar 2012 | A1 |
20120116438 | Salahieh et al. | May 2012 | A1 |
20120130171 | Barak et al. | May 2012 | A1 |
20120165669 | Barley et al. | Jun 2012 | A1 |
20120302877 | Harks et al. | Nov 2012 | A1 |
20130079645 | Amirana et al. | Mar 2013 | A1 |
20130085493 | Bloom et al. | Apr 2013 | A1 |
20130137920 | Schaeffer et al. | May 2013 | A1 |
20130138082 | Salahieh et al. | May 2013 | A1 |
20130172726 | Saadat et al. | Jul 2013 | A9 |
20130172883 | Lopes et al. | Jul 2013 | A1 |
20130178850 | Lopes et al. | Jul 2013 | A1 |
20130178851 | Lopes et al. | Jul 2013 | A1 |
20130204125 | Chang et al. | Aug 2013 | A1 |
20130204126 | Namati et al. | Aug 2013 | A1 |
20130231533 | Papademetriou et al. | Sep 2013 | A1 |
20130289350 | Lerner et al. | Oct 2013 | A1 |
20130304065 | Lopes et al. | Nov 2013 | A1 |
20130317497 | Edwards et al. | Nov 2013 | A1 |
20140031810 | Mahvi et al. | Jan 2014 | A1 |
20140058197 | Salahieh et al. | Feb 2014 | A1 |
20140107623 | Salahieh et al. | Apr 2014 | A1 |
20140121470 | Scharf et al. | May 2014 | A1 |
20140171942 | Werneth et al. | Jun 2014 | A1 |
20140180273 | Nair | Jun 2014 | A1 |
20140213850 | Levy et al. | Jul 2014 | A1 |
20140243680 | Raleigh | Aug 2014 | A1 |
20140296643 | Levy et al. | Oct 2014 | A1 |
20140296866 | Salman et al. | Oct 2014 | A1 |
20140309495 | Kirma et al. | Oct 2014 | A1 |
20140316198 | Krivopisk et al. | Oct 2014 | A1 |
20140320617 | Parks et al. | Oct 2014 | A1 |
20140333743 | Gilreath et al. | Nov 2014 | A1 |
20140357956 | Arnr Saiahieh et al. | Dec 2014 | A1 |
20140358140 | Emmons et al. | Dec 2014 | A1 |
20140364691 | Krivopisk et al. | Dec 2014 | A1 |
20140364692 | Salman et al. | Dec 2014 | A1 |
20140364694 | Avron et al. | Dec 2014 | A1 |
20140370072 | Hossainy et al. | Dec 2014 | A1 |
20150073341 | Salahieh et al. | Mar 2015 | A1 |
20150094656 | Salahieh et al. | Apr 2015 | A1 |
20150327753 | Amirana et al. | Nov 2015 | A1 |
20150351836 | Prutchi | Dec 2015 | A1 |
20160000500 | Salahieh et al. | Jan 2016 | A1 |
20160051321 | Salahieh et al. | Feb 2016 | A1 |
20160157954 | Sagon et al. | Jun 2016 | A1 |
20160345947 | Salahieh et al. | Dec 2016 | A1 |
20170027601 | Salahieh et al. | Feb 2017 | A1 |
20170042614 | Salahieh et al. | Feb 2017 | A1 |
20170042615 | Salahieh et al. | Feb 2017 | A1 |
20170080184 | Salahieh et al. | Mar 2017 | A1 |
20170080186 | Salahieh et al. | Mar 2017 | A1 |
20170143201 | Claude et al. | May 2017 | A1 |
20170173303 | Salahieh et al. | Jun 2017 | A1 |
20170203077 | Salahieh et al. | Jul 2017 | A1 |
Number | Date | Country |
---|---|---|
1085416 | Apr 1994 | CN |
1781161 | May 2006 | CN |
101511292 | Aug 2009 | CN |
101888813 | Nov 2010 | CN |
101956919 | Jan 2011 | CN |
4104092 | Aug 1991 | DE |
0322852 | Jul 1989 | EP |
0802768 | Oct 1997 | EP |
0637943 | Apr 1998 | EP |
623360 | Mar 1999 | EP |
0723467 | Apr 2002 | EP |
0693955 | Jan 2003 | EP |
1382366 | Jan 2004 | EP |
1463441 | Oct 2004 | EP |
1604613 | Dec 2005 | EP |
1991301 | Nov 2008 | EP |
2335757 | Jun 2011 | EP |
08504333 | May 1996 | JP |
2000504242 | Apr 2000 | JP |
2003510126 | Mar 2003 | JP |
2004237077 | Aug 2004 | JP |
2008142346 | Jun 2006 | JP |
2007516010 | Jun 2007 | JP |
2009507617 | Feb 2009 | JP |
2009539575 | Nov 2009 | JP |
2010507404 | Mar 2010 | JP |
2012525898 | Oct 2012 | JP |
WO8705748 | Sep 1987 | WO |
WO9505775 | Mar 1995 | WO |
WO9510319 | Apr 1995 | WO |
WO9831271 | Jul 1998 | WO |
WO9900060 | Jan 1999 | WO |
WO9902096 | Jan 1999 | WO |
WO9926530 | Jun 1999 | WO |
WO9942176 | Aug 1999 | WO |
WO9944519 | Sep 1999 | WO |
WO9945855 | Sep 1999 | WO |
WO0038580 | Jul 2000 | WO |
WO0056237 | Sep 2000 | WO |
WO0066014 | Nov 2000 | WO |
WO0067648 | Nov 2000 | WO |
WO0067656 | Nov 2000 | WO |
WO0108575 | Feb 2001 | WO |
WO0108576 | Feb 2001 | WO |
WO0113812 | Mar 2001 | WO |
WO0168178 | Sep 2001 | WO |
WO0172373 | Oct 2001 | WO |
WO0187169 | Nov 2001 | WO |
WO0187174 | Nov 2001 | WO |
WO0195820 | Dec 2001 | WO |
WO0240089 | May 2002 | WO |
WO03013624 | Feb 2003 | WO |
WO2005032370 | Apr 2005 | WO |
WO2005065563 | Jul 2005 | WO |
WO2006077573 | Jul 2006 | WO |
WO2007001981 | Jan 2007 | WO |
WO2007047993 | Apr 2007 | WO |
WO2007059195 | May 2007 | WO |
WO2008061152 | May 2008 | WO |
WO2009067695 | May 2009 | WO |
WO2009088678 | Jul 2009 | WO |
WO2009132137 | Oct 2009 | WO |
WO2009151600 | Dec 2009 | WO |
WO2009155441 | Dec 2009 | WO |
2011143468 | Nov 2011 | WO |
WO2011153434 | Dec 2011 | WO |
WO2012033837 | Mar 2012 | WO |
WO2013049601 | Apr 2013 | WO |
WO2013098732 | Jul 2013 | WO |
WO2014100259 | Jun 2014 | WO |
Entry |
---|
International Search Report and Written Opinion issued in PCT/US2016/062323, dated Apr. 5, 2017, 15 pages. |
Denham et al.; Ultrasonic resonant modes of piezoelectric balloons under internal pressure; J. Acoust. Soc. Am.; 132(3); pp. 1368-1377; Sep. 2012. |
Drafts, Bill; Acoustic wave technology sensors; Sensors Weekly (Questex Media Group); 10 pgs.; Oct. 1, 2000 (http://www.sensorsmag.com/sensors/acoustic-ultrasound/acoustic-wave-technology-sensors-936). |
Foley et al.; Computer Graphics Principles and Practice; 2nd Edition; Addison Wesley (publisher); pp. 835-843; Jun. 1990. |
Gibson; Visualization of lesion transmurality and depth of necrosis using an ablation catheter that incorporates ultrasound imaging: a small step or a major leap forward on the road to a more durable catheter ablation procedure for treatment of atrial fibrillation; Heart Rhythm; 8(2); pp. 313-314; Feb. 2011. |
Hu et al.; In-vivo pan/tilt endoscope with integrated light source; Intelligent Robots and Systems; IROS 2007. IEEE/RSJ International Conference on; pp. 1284-1289; San Diego, CA, USA: Oct. 29-Nov. 2, 2007. |
Wippermann et al.; Low cost video endoscopes with simplified integration; In SPIE Photonics Europe; International Society for Optics and Phtonics; vol. 7716; pp. 77160M-1-77160M-9; Apr. 30, 2010. |
Wright et al.; Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter; Heart Rhythm; 8(2); pp. 304-312; Feb. 2011. |
Wu et al.; Transmural ultrasound imaging of thermal lesion and action potential changes in perfused canine cardiac wedge preparations by high intensity focused ultrasound ablation; Plos One; 8(12); pp. 1-13; Dec. 2013. |
Salahieh et al.; U.S. Appl. No. 13/830,624 entitled “Local Sympathectomy for PVD,” filed Mar. 14, 2013. |
Salahieh et al.; U.S. Appl. No. 61/622,495 entitled “Energy Delivery Device with Rapid Exchange Features,” filed Apr. 10, 2012. |
Salahieh et al.; U.S. Appl. No. 61/624,206 entitled “Energy delivery device and methods of use,” filed Apr. 13, 2012. |
Salahieh et al.; U.S. Appl. No. 15/640,306 entitled “Ablation catheters,” filed Jun. 30, 2017. |
Extended European Search Report issued in EP Application 15811644.2, dated Dec. 12, 2017, 8 pages. |
Extended European Search Report issued in EP Application 14782484.1, dated Oct. 31, 2016, 9 pages. |
International Preliminary Report on Patentability issued in PCT/US2014/033393, dated Oct. 13, 2015, 11 pages. |
International Preliminary Report on Patentability issued in PCT/US2016/039646, dated Jan. 4, 2018, 6 pages. |
International Preliminary Report on Patentability issued in PCT/US2016/062323, dated May 31, 2018, 10 pages. |
International Search Report issued in PCT/US2014033393, dated Aug. 19, 2014, 5 pages. |
Salahieh et al,, U.S. Appl. No. 15/375,027, entilted “Steerable medical devices, systems, and methods of use,” filed Dec. 9, 2016. |
Salahieh et al., U.S. Appl. No. 15/082,923 entitled “Steerable Medical Devices, Systems, and Methods of Use,” filed Mar. 28, 2016. |
Salahieh et al., U.S. Appl. No. 15/092,442 entitled “Intravascular Tissue Disruption,” filed Apr. 6, 2016. |
Salahieh et al., U.S. Appl. No. 15/138,050 entitled “Steerable Medical Devices, Systems, and Methods of Use,” filed Apr. 25, 2016. |
Salahieh et al., U.S. Appl. No. 15/167,509 entitled “Intravascular Tissue Disruption,” filed May 27, 2016. |
Salahieh et al., U.S. Appl. No. 15/339,724 entitled “Ablation Catheters,” filed Oct. 31, 2016. |
Salahieh et al., U.S. Appl. No. 15/339,745 entitled “Ablation catheters,” filed Oct. 31, 2016. |
Salahieh et al., U.S. Appl. No. 15/452,413 entitled “Steerable delivery sheaths,” filed Mar. 7, 2017. |
Tymecki et al., “Strip thick-film silver ion-selective electrodes”, Sensors and Actuators B; 96(3); pp. 482-488, Dec. 1, 2003. |
Number | Date | Country | |
---|---|---|---|
20170333125 A1 | Nov 2017 | US |
Number | Date | Country | |
---|---|---|---|
62326546 | Apr 2016 | US | |
62309359 | Mar 2016 | US | |
62259596 | Nov 2015 | US | |
62255895 | Nov 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US2016/062323 | Nov 2016 | US |
Child | 15663523 | US |